<DOC>
	<DOCNO>NCT00557635</DOCNO>
	<brief_summary>Sometime osseous reconstruction need allogeneic bone , study use Ostéopure™ Ostéobanque d'Auvergne , osseous matrix . However Ostéopure™ integration last long time . To optimize integration purpose associate mesenchymal progenitor cell autologous bone marrow .</brief_summary>
	<brief_title>Osseous Setting Improvement With Co-implantation Osseous Matrix Mesenchymal Progenitors Cells From Autologous Bone Marrow</brief_title>
	<detailed_description>All patient treat tibia femur pseudo-arthrosis . At begin chirurgical intervention , autologous bone marrow sample concentrate one . Meanwhile osseous matrix ( Ostéopure™ ) incubate autologous blood serum finally implanted fracture site . And ( end chirurgical intervention ) , concentrate autologous bone marrow inject place .</detailed_description>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Pseudarthrosis</mesh_term>
	<criteria>tibia femur pseudoarthrosis , patient need bone graft contra indication chirurgical intervention bone graft</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>pseudo-arthrosis , osseous matrix , cell therapy</keyword>
</DOC>